VT-111

N/A

Report date: 2022/07/19 16:22:54

Base Information

Drug NameVT-111
Drug Alias NameSerine protease inhibitor-1VT-111bVT-111aSERP-1VT-111
ClassificationBiologics > Protein drugs > Recombinant protein
Mechanisms of ActionPeptide hydrolase inhibitorsSerine protease inhibitorsImmunosuppressants
TargetsSerine proteasePeptide hydrolase
Therapy Area/IndicationsCoronary RestenosisCoronary Artery DiseaseAngina, Unstable
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryCanadaUnited States
CombinationsNo
Global Highest StatusDiscontinued (Phase 2 Clinical)
Highest Status in ChinaN/A
Originator CompaniesViron Therapeutics Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesViron Therapeutics Inc
Active IndicationsN/A
Inactive IndicationsCoronary RestenosisCoronary Artery DiseaseAngina, Unstable

Other Information

ATC CodeN/A
Related LinksN/A